Skip to content
PeptideSport
Hims logo

Provider review

Hims review

Exited compounded semaglutide for new patients after a 2026 Novo Nordisk settlement

Hims, the men's telehealth brand from publicly traded Hims & Hers Health (NYSE: HIMS), settled with Novo Nordisk on March 9, 2026 and moved new patients to branded medication only — confirmed via corroborating dated reporting, since Hims' own site no longer explains the change on its pricing page. Its current public pricing mirrors its sister brand Hers: a Weight Loss Membership at $39 for the first month, auto-renewing at $149/month, confirmed live, with medication billed separately on top — Wegovy Pill or Ozempic Pill from $149/mo, Wegovy Pen or Ozempic injection from $199/mo, Zepbound Vial or KwikPen from $299/mo, up to $1,899/mo for Mounjaro or non-vial Zepbound. No compounded semaglutide or tirzepatide pricing appears on the live page.

Verified August 2026

Straight talk: how we earn — some, not all, of these are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.

On this page

The verdict

If you still think of Hims as the cheap-compounded-Ozempic brand, that's now out of date: as of a March 2026 settlement with Novo Nordisk, new patients are routed to branded medication only, confirmed via dated third-party reporting since Hims' own site doesn't narrate the change itself. What's left is a NYSE-listed company's credibility (real, and worth something) attached to the same stacked-fee structure as Hers: a $39-then-$149/mo membership that buys eligibility, not medication, with the drug itself billed separately at $149 to $1,899/mo. Worth knowing before you land on the site expecting the old compounded pricing.

Hims is not ranked on any of our boards. This is a standalone read of what the company publishes about itself — the providers we do rank in this category are on our semaglutide provider ranking. Nothing on this page is a performance claim — see the evidence review for what these compounds do and do not do.

Who it is for, and who it is not

A good fit if

  • You want the credibility of a publicly traded parent company (Hims & Hers Health, NYSE: HIMS)
  • You specifically want FDA-approved branded medication (Wegovy, Zepbound, Ozempic, or oral Foundayo)
  • You have commercial insurance and a savings card that could substantially lower the branded price — worth confirming directly, not assumed here

Look elsewhere if

  • You came for the compounded semaglutide pricing Hims was previously known for — new patients no longer get that option
  • You want a single all-in price rather than a membership fee plus separately billed medication
  • You want a stated money-back or results guarantee — none was found in the public FAQ content

What it actually costs

What they advertise

Weight Loss Membership: $39 for the first month, confirmed live on hims.com/weight-loss.

What you actually pay, month to month

Membership auto-renews at $149/month, and medication is billed separately on top, from $149/mo up to $1,899/mo depending on drug.

The commitment trap

The $39 teaser is a membership fee only; medication is a separate charge on top of the $149/mo membership, and compounded pricing is no longer offered to new patients.

Money you will meet later

  • Medication cost is separate from and additional to the membership fee

Checked live on Hims's own site at https://www.hims.com/weight-loss in August 2026. Prices change without notice — confirm before you buy. Work out what a vial actually gives you with our peptide dose calculator.

What is included

The cheapest headline number in this category is often the one with the least attached to it. Here is what Hims bundles in, and what it does not.

Clinician consult

Clinician evaluation through the membership, confirmed live.

Bloodwork / labs

Not addressed in the sources read.

Follow-ups and dose changes

Not addressed with a specific cadence in the sources read.

Human support

Not addressed with specifics in the sources read.

Injection supplies

Not itemized separately from medication pricing in the sources…

read.

Shipping

Not addressed with specific terms in the sources read.

Pharmacy, labs and oversight

The pharmacy

Not named on the public weight-loss pricing page, confirmed live.

Oversight

Clinician evaluation through the membership, confirmed live. Not addressed with a specific cadence in the sources read.

Compounded peptides are not FDA-approved products, and a 503A pharmacy compounds for a named patient while a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Our guide to verifying a certificate of analysis covers what to ask for.

Where you can get it

Site states GLP-1s are "not yet available in all 50 states," with no published list, confirmed live.

The honest cons

The part they would rather you skipped

Hims quietly exited compounded semaglutide for new patients after a March 2026 Novo Nordisk settlement — its own site doesn't explain the change, so if you're comparing it on its old reputation for cheap compounded GLP-1s, that reputation is now out of date.

  • No longer offers compounded semaglutide or tirzepatide to new patients as of March 2026
  • Membership fee ($39 then $149/mo) is separate from and does not include medication cost
  • No money-back or results guarantee found in public FAQ content
  • No state coverage list published, only a general "not all 50 states" disclaimer

None of this is unique to Hims — the whole category shares it. What we hold against a provider is the part it hides, and the ways vendors hide things are catalogued in our vendor red-flags guide.

How it compares

Read this before you buy

A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.

Facts on this page reflect Hims's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on Hims's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.